Academic Bibliography

Show Sort by

Your filters: cql: author="Saunders, Michael" or (type exact bookEditor and editor="Saunders, Michael")

Mark
- journalArticle
- A1
- open access
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy

Marie Godar (UGent) , Virginia Morello, Ava Sadi, Anna Hultberg, Natalie De Jonge, Cristina Basilico, Valérie Hanssens, Michael Saunders, Bart Lambrecht (UGent) , Mohamed El Khattabi, et al.

(2016) SCIENTIFIC REPORTS. 6.
Mark
Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling

Anna Hultberg, Virginia Morello, Leander Huyghe, Natalie De Jonge, Christophe Blanchetot, Valérie Hanssens, Gitte de Boeck, Karen Silence, Els Festjens, Raimond Heukers, et al.

(2015) CANCER RESEARCH. 75(16). p.3373-3383
Mark
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade

Karen Silence, Torsten Dreier, Mahan Moshir, Peter Ulrichts, Sofie ME Gabriels, Michael Saunders, Harald Wajant, Peter Brouckaert (UGent) , Leander Huyghe (UGent) , Tim Van Hauwermeiren, et al.

(2014) MABS. 6(2). p.523-532
Mark
- journalArticle
- A1
- open access
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules

Anna Hultberg, Nigel J Temperton, Valérie Rosseels, Mireille Koenders, Maria Gonzalez-Pajuelo, Bert Schepens (UGent) , Lorena Ibanez (UGent) , Peter Vanlandschoot, Joris Schillemans, Michael Saunders, et al.

(2011) PLOS ONE. 6(4).

Academic Bibliography

Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy

Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade

Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules

Contents

Support

Contact